Scout | Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery

This opportunity is no longer accepting applications.

grant

Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery

This grant opportunity aims to support early-stage research for creating new malaria vaccines or treatments using monoclonal antibodies. It focuses on developing combination vaccines, vaccines that provide broad protection, and improving how these products are delivered and made. The overall goal is to increase the number of potential options for preventing malaria worldwide.

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Allergy and Infectious Diseases

Dates

Opportunity Released: November 20, 2024

Keywords

malaria

vaccine development

monoclonal antibodies

translational research

combination vaccines

broadly protective vaccines

malaria prevention

antibody discovery

vaccine candidates

global health

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers